Stockscreener 앱 받기
36.20
2.32%
0.82
시간 외 거래:
36.11
-0.09
-0.25%
Roundhill Glp 1 Weight Loss Etf 주식(OZEM)의 최신 뉴스
New Year, New Strategy: Navigating Weight Loss ETFs - ETF Database
Insiders Bullish on Certain Holdings of OZEM - Nasdaq
How Roundhill Etf Trust Glp-1 & Weight Loss Etf (OZEM) Affects Rotational Strategy Timing - Stock Traders Daily
The Obesity Pill Rush: Healthcare ETFs to Gain as FDA Nods to Novo Drug - The Globe and Mail
Discipline and Rules-Based Execution in OZEM Response - Stock Traders Daily
6 Top-Performing ETF Areas of Last Week - sharewise.com
(OZEM) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Can You Buy Ozempic Stock in 2025? - The Motley Fool
Best-Performing ETFs of November - TradingView — Track All Markets
Roundhill Glp-1 & Weight Loss ETF (OZEM) stock price, news, quote and history - Yahoo Finance UK
Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk - Benzinga
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in - TradingView
Why (OZEM) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Why Is Roundhill Glp-1 & Weight Loss ETF (OZEM) Stock Up Today? - Meyka
Understanding Momentum Shifts in (OZEM) - news.stocktradersdaily.com
5 Sector ETFs Up 10% Despite February's Market Slump - MSN
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data - MSN
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain - Benzinga
The Investor's Guide to Buying GLP-1 Stocks - The Motley Fool
Avoiding Lag: Real-Time Signals in (OZEM) Movement - news.stocktradersdaily.com
Roundhill GLP-1 & Weight Loss ETF (NQ: OZEM - FinancialContent
Are You Making These 3 ETF Mistakes That Cost You 50% in Gains? - The Motley Fool
N-PX: Others - 富途牛牛
NVO Wins FDA Approval for MASH Treatment: ETFs Likely to Gain - sg.finance.yahoo.com
Investing in the Dip: Evaluating ETF Exposure to Eli Lilly Amid Sector Volatility and GLP-1 Growth - AInvest
Will drop go up or down throughout this week - AInvest
Novo Nordisk Shares Plunge, Drag Down Weight-Loss-Drug ETFs - ETF.com
Weight-Loss Drug ETFs Generate Skinnier Returns Than Expected - The Daily Upside
HRTS: Effectively Thinning Investor Portfolios - ETF.com
The GLP-1 Boom: Why OZEM is Poised to Capitalize on the Obesity Drug Revolution - AInvest
ETFs to Capitalize on the Novo Nordisk-Septerna Deal - Yahoo Finance
OZEMRoundhill GLP-1 & Weight Loss ETF Latest Stock News & Market Updates - Stock Titan
Roundhill GLP-1 & Weight Loss ETF Review and Aggregate Rating (OZEM) - MarketBeat
New Year's Resolutions: Lose Weight & Allocate to GLP-1 ETFs - ETF Trends
Eli Lilly Cuts Q4 Sales Forecast: ETFs to Buy on the Dip - Nasdaq
Disruptive Theme of the Week: 2024's Top Investment Themes & Trends - ETF Trends
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Roundhill GLP-1 & Weight Loss ETF (NASDAQ: OZEM)Dividends - intelligentinvestor.com.au
Tap the Weight-Loss Drug Market With These ETFs - TradingView — Track All Markets
Ozempic and Weight Loss Drug ETFs Back in Spotlight After Key Earnings Results - Trackinsight
0.02%
0.27%
자본화:
|
볼륨(24시간):